** Shares of healthcare technology company R1 RCM RCM.O
rise 9.2% to ~$14 in premarket trading
** Co entered into an agreement to be acquired by private
equity firms TowerBrook Capital Partners and Clayton, Dubilier &
Rice (CD&R) in a deal worth $8.9 bln, including debt
** Upon completion of the transaction, expected to close by
the year end, RCM will become a private company and its shares
will no longer trade on Nasdaq
** The PE firms will acquire remaining shares of R1 RCM that
TowerBrook does not currently own for $14.30/share
** RCM provides services for billing and revenue collection
to hospitals, physician groups and other healthcare
organizations
** As of last close, stock up about 22% so far this year
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com;))